KMDA
Price
$7.88
Change
+$0.14 (+1.81%)
Updated
Jul 3 closing price
Capitalization
306.49M
37 days until earnings call
RGC
Price
$22.99
Change
+$12.63 (+121.91%)
Updated
Jul 3 closing price
Capitalization
50.75M
Interact to see
Advertisement

KMDA vs RGC

Header iconKMDA vs RGC Comparison
Open Charts KMDA vs RGCBanner chart's image
Kamada
Price$7.88
Change+$0.14 (+1.81%)
Volume$23.33K
Capitalization306.49M
Regencell Bioscience Holdings
Price$22.99
Change+$12.63 (+121.91%)
Volume$18.8M
Capitalization50.75M
KMDA vs RGC Comparison Chart in %
Loading...
KMDA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RGC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
KMDA vs. RGC commentary
Jul 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is KMDA is a StrongBuy and RGC is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 07, 2025
Stock price -- (KMDA: $7.88 vs. RGC: $22.99)
Brand notoriety: KMDA and RGC are both not notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: KMDA: 31% vs. RGC: 553%
Market capitalization -- KMDA: $306.49M vs. RGC: $50.75M
KMDA [@Pharmaceuticals: Other] is valued at $306.49M. RGC’s [@Pharmaceuticals: Other] market capitalization is $50.75M. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $77.48B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $3.78B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

KMDA’s FA Score shows that 1 FA rating(s) are green whileRGC’s FA Score has 0 green FA rating(s).

  • KMDA’s FA Score: 1 green, 4 red.
  • RGC’s FA Score: 0 green, 5 red.
According to our system of comparison, KMDA is a better buy in the long-term than RGC.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

KMDA’s TA Score shows that 4 TA indicator(s) are bullish while RGC’s TA Score has 4 bullish TA indicator(s).

  • KMDA’s TA Score: 4 bullish, 4 bearish.
  • RGC’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, KMDA is a better buy in the short-term than RGC.

Price Growth

KMDA (@Pharmaceuticals: Other) experienced а -0.25% price change this week, while RGC (@Pharmaceuticals: Other) price change was +13.87% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +2.02%. For the same industry, the average monthly price growth was +2.94%, and the average quarterly price growth was +92.60%.

Reported Earning Dates

KMDA is expected to report earnings on Aug 13, 2025.

Industries' Descriptions

@Pharmaceuticals: Other (+2.02% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
KMDA($306M) has a higher market cap than RGC($50.8M). RGC YTD gains are higher at: 17584.475 vs. KMDA (33.100). KMDA has higher annual earnings (EBITDA): 22.4M vs. RGC (-4.67M). KMDA has more cash in the bank: 55.6M vs. RGC (306K). RGC has less debt than KMDA: RGC (3.54M) vs KMDA (8.82M). KMDA has higher revenues than RGC: KMDA (143M) vs RGC (0).
KMDARGCKMDA / RGC
Capitalization306M50.8M602%
EBITDA22.4M-4.67M-479%
Gain YTD33.10017584.4750%
P/E Ratio37.43N/A-
Revenue143M0-
Total Cash55.6M306K18,170%
Total Debt8.82M3.54M249%
FUNDAMENTALS RATINGS
KMDA vs RGC: Fundamental Ratings
KMDA
RGC
OUTLOOK RATING
1..100
1550
VALUATION
overvalued / fair valued / undervalued
1..100
73
Overvalued
94
Overvalued
PROFIT vs RISK RATING
1..100
98100
SMR RATING
1..100
80100
PRICE GROWTH RATING
1..100
4034
P/E GROWTH RATING
1..100
28100
SEASONALITY SCORE
1..100
50n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

KMDA's Valuation (73) in the Biotechnology industry is in the same range as RGC (94) in the Movies Or Entertainment industry. This means that KMDA’s stock grew similarly to RGC’s over the last 12 months.

KMDA's Profit vs Risk Rating (98) in the Biotechnology industry is in the same range as RGC (100) in the Movies Or Entertainment industry. This means that KMDA’s stock grew similarly to RGC’s over the last 12 months.

KMDA's SMR Rating (80) in the Biotechnology industry is in the same range as RGC (100) in the Movies Or Entertainment industry. This means that KMDA’s stock grew similarly to RGC’s over the last 12 months.

RGC's Price Growth Rating (34) in the Movies Or Entertainment industry is in the same range as KMDA (40) in the Biotechnology industry. This means that RGC’s stock grew similarly to KMDA’s over the last 12 months.

KMDA's P/E Growth Rating (28) in the Biotechnology industry is significantly better than the same rating for RGC (100) in the Movies Or Entertainment industry. This means that KMDA’s stock grew significantly faster than RGC’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
KMDARGC
RSI
ODDS (%)
Bearish Trend 4 days ago
83%
Bearish Trend 4 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 4 days ago
68%
Bullish Trend 4 days ago
90%
Momentum
ODDS (%)
Bullish Trend 4 days ago
73%
Bearish Trend 4 days ago
90%
MACD
ODDS (%)
Bullish Trend 4 days ago
74%
Bearish Trend 4 days ago
85%
TrendWeek
ODDS (%)
Bearish Trend 4 days ago
68%
Bullish Trend 4 days ago
81%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
69%
Bullish Trend 4 days ago
83%
Advances
ODDS (%)
Bullish Trend 27 days ago
67%
Bullish Trend 20 days ago
85%
Declines
ODDS (%)
Bearish Trend 24 days ago
67%
Bearish Trend 5 days ago
89%
BollingerBands
ODDS (%)
Bearish Trend 4 days ago
65%
Bearish Trend 4 days ago
81%
Aroon
ODDS (%)
Bullish Trend 4 days ago
69%
Bullish Trend 4 days ago
83%
View a ticker or compare two or three
Interact to see
Advertisement
KMDA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RGC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
MRMD0.09N/A
+0.70%
MariMed Inc.
KPCPF4.60N/A
N/A
KASIKORNBANK Public Co. Ltd.
MCUJF0.91N/A
N/A
Medicure Inc.
PTIZF1.32N/A
N/A
PT Indo Tambangraya Megah
KOGL57.00N/A
N/A
Kopp Glass, Inc.

KMDA and

Correlation & Price change

A.I.dvisor tells us that KMDA and OGI have been poorly correlated (+30% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that KMDA and OGI's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KMDA
1D Price
Change %
KMDA100%
+1.81%
OGI - KMDA
30%
Poorly correlated
+3.62%
RDY - KMDA
28%
Poorly correlated
+1.34%
AMRX - KMDA
26%
Poorly correlated
+0.60%
ELAN - KMDA
24%
Poorly correlated
-0.54%
HROW - KMDA
24%
Poorly correlated
+3.86%
More

RGC and

Correlation & Price change

A.I.dvisor tells us that RGC and CLCFF have been poorly correlated (+21% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that RGC and CLCFF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RGC
1D Price
Change %
RGC100%
+121.91%
CLCFF - RGC
21%
Poorly correlated
N/A
QNTM - RGC
21%
Poorly correlated
-10.96%
SBFM - RGC
20%
Poorly correlated
-6.06%
INCR - RGC
8%
Poorly correlated
+5.41%
KMDA - RGC
6%
Poorly correlated
+1.81%
More